Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 85
- −2 vs. Q1 2024
- Portfolio value
- $2.35B
- −$460.1M (−16.4%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ISRGIntuitive Surgical Inc | COM NEW | 245,000 | $109.0M | 4.6% | +19,000+8.4% | Added | History |
| BSXBoston Scientific Corp | Stock | 1,170,100 | $90.1M | 3.8% | −785,900−40.2% | Reduced | History |
| NTRANatera, Inc. | COM | 766,500 | $83.0M | 3.5% | −36,800−4.6% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,987,845 | $79.5M | 3.4% | +2,655+0.1% | Added | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,120,000 | $75.6M | 3.2% | +115,000+11.4% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,917,231 | $75.5M | 3.2% | +199,677+7.3% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,335,000 | $68.5M | 2.9% | +922,500+38.2% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 491,000 | $67.6M | 2.9% | −45,500−8.5% | Reduced | History |
| AVTRAvantor, Inc. | COM | 3,086,000 | $65.4M | 2.8% | +391,000+14.5% | Added | History |
| CICigna Group | Stock | 184,500 | $61.0M | 2.6% | 00.0% | Unchanged | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 544,500 | $58.1M | 2.5% | −39,500−6.8% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 222,000 | $53.9M | 2.3% | −21,000−8.6% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 48,000 | $50.4M | 2.1% | −20,000−29.4% | Reduced | History |
| ILMNIllumina, Inc. | COM | 478,000 | $49.9M | 2.1% | +13,900+3.0% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 372,000 | $49.5M | 2.1% | −229,000−38.1% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 277,800 | $47.6M | 2.0% | +50,800+22.4% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 80,000 | $44.2M | 1.9% | +43,400+118.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,075,000 | $42.2M | 1.8% | +211,000+24.4% | Added | History |
| BPMCBlueprint Medicines Corp | COM | 383,000 | $41.3M | 1.8% | −43,000−10.1% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 1,296,225 | $40.9M | 1.7% | −158,540−10.9% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 325,000 | $40.2M | 1.7% | −177,000−35.3% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 960,000 | $39.5M | 1.7% | +26,500+2.8% | Added | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,117,000 | $39.2M | 1.7% | +317,300+39.7% | Added | History |
| DHRDanaher Corp | Stock | 150,000 | $37.5M | 1.6% | +6,200+4.3% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 840,219 | $35.2M | 1.5% | +455,974+118.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 110,000 | $35.0M | 1.5% | −107,000−49.3% | Reduced | History |
| INCYIncyte Corp | COM | 529,000 | $32.1M | 1.4% | +529,000 | New | History |
| SGRYSurgery Partners, Inc. | Stock | 1,306,477 | $31.1M | 1.3% | −138,523−9.6% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 3,037,668 | $30.3M | 1.3% | +3,037,668 | New | History |
| AXSMAxsome Therapeutics, Inc. | COM | 376,000 | $30.3M | 1.3% | −55,000−12.8% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 754,000 | $29.4M | 1.2% | +44,000+6.2% | Added | History |
| DXCMDexcom Inc | COM | 259,000 | $29.4M | 1.2% | +82,100+46.4% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 755,000 | $29.3M | 1.2% | +120,000+18.9% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 430,000 | $28.8M | 1.2% | +430,000 | New | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 400,000 | $27.4M | 1.2% | −200,000−33.3% | Reduced | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,559,826 | $27.2M | 1.2% | +1,559,826 | New | History |
| GKOSGLAUKOS Corp | COM | 224,000 | $26.5M | 1.1% | 00.0% | Unchanged | History |
| NGNENeurogene Inc. | COM | 727,537 | $26.5M | 1.1% | +262,300+56.4% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 60,500 | $26.0M | 1.1% | +60,500 | New | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 731,104 | $25.0M | 1.1% | −411,746−36.0% | Reduced | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 531,000 | $24.1M | 1.0% | +306,000+136.0% | Added | History |
| IMVTImmunovant, Inc. | COM | 908,000 | $24.0M | 1.0% | +403,000+79.8% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,100,000 | $23.7M | 1.0% | +75,000+7.3% | Added | History |
| LNTHLantheus Holdings, Inc. | Stock | 290,000 | $23.3M | 1.0% | −190,000−39.6% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 284,000 | $21.4M | 0.9% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 487,000 | $19.2M | 0.8% | +102,107+26.5% | Added | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 782,000 | $17.8M | 0.8% | +22,000+2.9% | Added | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $17.7M | 0.8% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 398,000 | $17.6M | 0.7% | −270,300−40.4% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 255,000 | $17.5M | 0.7% | +255,000 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,620,000 | $16.7M | 0.7% | −115,000−6.6% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 205,000 | $16.0M | 0.7% | +45,000+28.1% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 343,200 | $15.7M | 0.7% | +133,500+63.7% | Added | History |
| BHVNBiohaven Ltd. | COM | 450,000 | $15.6M | 0.7% | +375,000+500.0% | Added | History |
| SNYSanofi | SPONSORED ADR | 315,000 | $15.3M | 0.6% | +315,000 | New | History |
| RGNXREGENXBIO Inc. | COM | 1,300,064 | $15.2M | 0.6% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $14.9M | 0.6% | +7,419,355 | New | History |
| EXASExact Sciences Corp | COM | 338,500 | $14.3M | 0.6% | +338,500 | New | History |
| PRVAPrivia Health Group, Inc. | COM | 764,200 | $13.3M | 0.6% | 00.0% | Unchanged | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 559,300 | $10.7M | 0.5% | +84,300+17.7% | Added | History |
| IMNMImmunome Inc. | COM | 873,891 | $10.6M | 0.4% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 8,902,972 | $9.88M | 0.4% | 00.0% | Unchanged | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 215,600 | $9.76M | 0.4% | +215,600 | New | History |
| Cybin Ord23256X100 | COM | 34,884,000 | $9.45M | 0.4% | 00.0% | Unchanged | – |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,673,538 | $8.64M | 0.4% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 1,000,706 | $8.44M | 0.4% | +555,000+124.5% | Added | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $6.78M | 0.3% | −86,400−30.2% | Reduced | History |
| TYRATyra Biosciences, Inc. | COM | 373,000 | $5.96M | 0.3% | +373,000 | New | History |
| PATHUiPath, Inc. | Stock | 362,000 | $4.59M | 0.2% | +362,000 | New | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 195,000 | $4.58M | 0.2% | +195,000 | New | History |
| IMTXImmatics N.V. | SHS | 393,100 | $4.57M | 0.2% | +393,100 | New | History |
| IONSIonis Pharmaceuticals Inc | COM | 93,000 | $4.43M | 0.2% | −37,000−28.5% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,000,000 | $3.83M | 0.2% | +1,000,000 | New | History |
| EDITEditas Medicine, Inc. | COM | 816,000 | $3.81M | 0.2% | +816,000 | New | History |
| NTLAIntellia Therapeutics, Inc. | COM | 170,000 | $3.80M | 0.2% | +170,000 | New | History |
| COLLCollegium Pharmaceutical, Inc | COM | 117,000 | $3.77M | 0.2% | −244,400−67.6% | Reduced | History |
| PRMEPrime Medicine, Inc. | COM | 694,000 | $3.57M | 0.2% | −1,296,000−65.1% | Reduced | History |
| ACIUAC Immune SA | SHS | 825,000 | $3.29M | 0.1% | −3,645,000−81.5% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 5,026,000 | $3.02M | 0.1% | 00.0% | Unchanged | History |
| SCYXScynexis Inc | COM NEW | 1,448,728 | $2.90M | 0.1% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 2,018,500 | $1.75M | 0.1% | −6,280,070−75.7% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 350,000 | $1.75M | 0.1% | +350,000 | New | History |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $1.01M | <0.1% | 00.0% | Unchanged | History |
| CMAXCareMax, Inc. | COMM STK | 21,200 | $59.1K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 12,136 | $1.94K | <0.1% | −77,407−86.4% | Reduced | – |
Sold out since Q1 2024 (20)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| FUSNFusion Pharmaceuticals Inc. | COM | 6,500,328 | $138.6M | 4.9% | History |
| ALGNAlign Technology Inc | COM | 189,000 | $62.0M | 2.2% | History |
| LLYEli Lilly & Co | Stock | 70,000 | $54.5M | 1.9% | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,174,700 | $46.6M | 1.7% | History |
| CVSCVS Health Corp | Stock | 545,000 | $43.5M | 1.5% | History |
| CRBUCaribou Biosciences, Inc. | COM | 5,785,352 | $29.7M | 1.1% | History |
| MCKMcKesson Corp | Stock | 33,300 | $17.9M | 0.6% | History |
| VERAVera Therapeutics, Inc. | CL A | 383,500 | $16.5M | 0.6% | History |
| ATXSAstria Therapeutics, Inc. | COM | 982,000 | $13.8M | 0.5% | History |
| CYTKCytokinetics Inc | COM NEW | 166,000 | $11.6M | 0.4% | History |
| RDNTRadNet, Inc. | COM | 238,000 | $11.6M | 0.4% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 588,500 | $10.9M | 0.4% | History |
| IPSCCentury Therapeutics, Inc. | COM | 1,221,555 | $5.11M | 0.2% | History |
| KYTXKyverna Therapeutics, Inc. | COM | 202,333 | $5.03M | 0.2% | History |
| EBSEmergent BioSolutions Inc. | COM | 1,908,000 | $4.83M | 0.2% | History |
| ANTXAN2 Therapeutics, Inc. | COM | 1,150,000 | $3.74M | 0.1% | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A SHS | 3,000,000 | $3.48M | 0.1% | History |
| XFORX4 Pharmaceuticals, Inc | COM | 2,413,000 | $3.35M | 0.1% | History |
| PACBPacific Biosciences of California, Inc. | COM | 675,000 | $2.53M | 0.1% | History |
| KODKodiak Sciences Inc. | COM | 300,000 | $1.58M | 0.1% | History |